Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry-Reference-Cited by-同舟云学术

Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry

Published:2014-03-07 Issue:7 Volume:64 Page:1004-1013
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Köbel Martin¹,Bak Julia²,Bertelsen Björn I³,Carpen Olli⁴,Grove Anni⁵,Hansen Estrid S⁶,Levin Jakobsen Anne-Marie⁷,Lidang Marianne⁸,Måsbäck Anna⁹,Tolf Anna¹⁰,Gilks C Blake¹¹,Carlson Joseph W¹²^ORCID

Affiliation:

1. Department of Pathology and Laboratory Medicine; Calgary Laboratory Services and University of Calgary; Calgary AB Canada

2. Department of Pathology; Linköping University Hospital; Linköping Sweden

3. Department of Pathology; Haukeland University Hospital; Bergen Norway

4. Department of Pathology; University of Turku and Turku University Hospital; Turku Finland

5. Institute of Pathology; Aarhus University Hospital; Aarhus Denmark

6. Department of Pathology; Aarhus University Hospital; Aarhus Denmark

7. Department of Pathology; Umeå University Hospital; Umeå Sweden

8. Department of Pathology; Herlev University Hospital; Herlev Denmark

9. Department of Pathology; Lund University Hospital; Lund Sweden

10. Department of Pathology; Uppsala University Hospital; Uppsala Sweden

11. Department of Pathology and Laboratory Medicine; Vancouver General Hospital and University of British Columbia; Vancouver BC Canada

12. Department of Pathology and Cytology and Institution for Oncology-Pathology; Karolinska University Hospital; Stockholm Sweden

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12349/fullpdf

Reference38 articles.

1. Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates;Gurung;Histopathology,2013

2. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features;Prat;Virchows Arch.,2012

3. Are all pelvic (nonuterine) serous carcinomas of tubal origin?;Przybycin;Am. J. Surg. Pathol.,2010

4. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention;Carlson;J. Clin. Oncol.,2008

5. Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low and high grade disease and the role of the fallopian tube;Carlson;Diagn. Histopathol.,2008

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Progression and Prospects of the Gene Expression Profiling in Ovarian Epithelial Cancer;Gynecology and Minimally Invasive Therapy;2024-07

2. Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics;Frontiers in Oncology;2024-05-30

3. Machine Learning-driven Histotype Diagnosis of Ovarian Carcinoma: Insights from the OCEAN AI Challenge;2024-04-23

4. Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA;Human Cell;2024-04-04

5. Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non‐high‐grade serous ovarian carcinomas;The Journal of Pathology;2023-10-18